Skip to main content

Israeli COVID-19 vaccine pill to begin human trials

Israel is home to a few experimental treatments for the coronavirus.

An Israeli pharmaceutical company will soon begin testing its COVID-19 vaccine pill on humans.

Oramed Pharmaceuticals Inc. announced today that its subsidiary Oravax received permission from South African authorities to begin the first phase of the oral vaccine’s trial. Oramed can begin enrolling patients for the trial and is currently preparing to actually begin administering the pill, according to the Jerusalem-based firm’s statement.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.


Only $100 for annual access.